Justin welcomes Izotropic CEO Dr. John McGraw, to discuss prototype updates, specifically how the pandemic has impacted the companies timelines. Supply chains and delivery interruptions have impacted many companies during the covid pandemic. Dr. John McGraw states a big goal for Izotropic is to keep the overall timeline on track, in the meantime the company is using this time to optimize the clinical trial path.
Izotropic Corporation is the only publicly-traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers.IzoView produces high resolution breast images in true 3D with low radiation dose levels,and is ideal for imaging patients with dense breast tissue. A single 10 second scan acquires approximately 500 images, without painful breastcompression or continual technician breast handling, providing a more comfortable patient experience.
CSE:IZO | OTCQB:IZOZF